Lilly Reports First-Quarter 2017 Results

Go back to Lilly Reports First-Quarter 2017 Results

Eli Lilly (LLY) PT Lowered to $92 at Jefferies; Reiterates Buy

April 26, 2017 9:10 AM EDT

Jefferies lowered its price target on Eli Lilly (NYSE: LLY) to $92.00 (from $94.00) while maintaining a Buy rating. Jefferies lowered EPS estimates by up to 7% mid term and are now mostly in line with consensus over the next few years.

Jefferies' revenue estimates... More